A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.
PHASE1
Phase 1 study to evaluate two doses of Alum Adjuvanted Zika Virus Purified ...
Status
Completed
Location
Walter Reed Army Institute of Research - Clinical Trials Center
Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area
PHASE1
This study is randomized, double-blinded, placebo-controlled, Phase 1, dose...